GlaxoSmithKline PLC Director/PDMR Shareholding (7388T)
October 16 2017 - 11:52AM
UK Regulatory
TIDMGSK
RNS Number : 7388T
GlaxoSmithKline PLC
16 October 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Ms E Walmsley
=== ======================== ================================================
b) Position/status Chief Executive Officer
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 October 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- --------------------------------
GBP15.275 75.595 (personal contribution)
---------- --------------------------------
GBP15.275 187.204 (personal contribution)
---------- --------------------------------
GBP15.275 203.821 (personal contribution)
---------- --------------------------------
GBP15.275 75.595 (personal contribution)
---------- --------------------------------
GBP15.275 187.191 (personal contribution)
---------- --------------------------------
GBP15.275 203.809 (personal contribution)
---------- --------------------------------
GBP15.275 75.595 (matching shares)
---------- --------------------------------
GBP15.275 187.204 (matching shares)
---------- --------------------------------
GBP15.275 203.821 (matching shares)
---------- --------------------------------
GBP15.275 75.595 (matching shares)
---------- --------------------------------
GBP15.275 187.191 (matching shares)
---------- --------------------------------
GBP15.275 203.809 (matching shares)
---------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
1,866.43
GBP15.275
=== ======================== ================================================
e) Date of the transaction 2017-10-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr R G Connor
=== ======================== ================================================
b) Position/status President, Global Manufacturing & Supply
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 October 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- --------------------------------
GBP15.275 55.361 (personal contribution)
---------- --------------------------------
GBP15.275 127.190 (personal contribution)
---------- --------------------------------
GBP15.275 106.128 (personal contribution)
---------- --------------------------------
GBP15.275 55.361 (personal contribution)
---------- --------------------------------
GBP15.275 106.115 (personal contribution)
---------- --------------------------------
GBP15.275 55.361 (matching shares)
---------- --------------------------------
GBP15.275 127.19 (matching shares)
---------- --------------------------------
GBP15.275 106.128 (matching shares)
---------- --------------------------------
GBP15.275 55.361 (matching shares)
---------- --------------------------------
GBP15.275 106.115 (matching contribution)
---------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
900.310
GBP15.275
=== ======================== ================================================
e) Date of the transaction 2017-10-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr L Debruyne
=== ======================== ================================================
b) Position/status President, Global Vaccines
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 October2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- --------------------------------
GBP15.275 178.377 (personal contribution)
---------- --------------------------------
GBP15.275 178.365 (personal contribution)
---------- --------------------------------
GBP15.275 178.377 (matching shares)
---------- --------------------------------
GBP15.275 178.365 (matching shares)
---------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
713.484
GBP15.275
=== ======================== ================================================
e) Date of the transaction 2017-10-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr S Dingemans
=== ======================== ================================================
b) Position/status Chief Financial Officer
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 October 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- --------------------------------
GBP15.275 105.590 (personal contribution)
---------- --------------------------------
GBP15.275 247.218 (personal contribution)
---------- --------------------------------
GBP15.275 185.166 (personal contribution)
---------- --------------------------------
GBP15.275 105.576 (personal contribution)
---------- --------------------------------
GBP15.275 247.205 (personal contribution)
---------- --------------------------------
GBP15.275 185.166 (personal contribution)
---------- --------------------------------
GBP15.275 105.590 (matching shares)
---------- --------------------------------
GBP15.275 247.218 (matching shares)
---------- --------------------------------
GBP15.275 185.166 (matching shares)
---------- --------------------------------
GBP15.275 105.576 (matching shares)
---------- --------------------------------
GBP15.275 247.205 (matching shares)
---------- --------------------------------
GBP15.275 185.166 (matching shares)
---------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
2,151.842
GBP15.275
=== ======================== ================================================
e) Date of the transaction 2017-10-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr N Hirons
=== ======================== ================================================
b) Position/status SVP, Global Ethics & Compliance
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 October2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- -------------------------------
GBP15.275 38.762 (personal contribution)
---------- -------------------------------
GBP15.275 91.407 (personal contribution)
---------- -------------------------------
GBP15.275 67.081 (personal contribution)
---------- -------------------------------
GBP15.275 38.762 (personal contribution)
---------- -------------------------------
GBP15.275 91.407 (personal contribution)
---------- -------------------------------
GBP15.275 67.068 (personal contribution)
---------- -------------------------------
GBP15.275 38.762 (matching shares)
---------- -------------------------------
GBP15.275 91.407 (matching shares)
---------- -------------------------------
GBP15.275 67.081 (matching shares)
---------- -------------------------------
GBP15.275 38.762 (matching shares)
---------- -------------------------------
GBP15.275 91.407 (matching shares)
---------- -------------------------------
GBP15.275 67.068 (matching shares)
---------- -------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
788.974
GBP15.275
=== ======================== ================================================
e) Date of the transaction 2017-10-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr B McNamara
=== ======================== ===============================================
b) Position/status CEO, GSK Consumer Healthcare
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 12 October 2017 on ADSs
held in the Company's 2009 Deferred Annual
Bonus Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- -------------------------------
$41.020 75.963 (personal contribution)
--------- -------------------------------
$41.020 75.963 (matching shares)
--------- -------------------------------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
151.926
$41.020
=== ======================== ===============================================
e) Date of the transaction 2017-10-12
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr D S Redfern
=== ======================== ================================================
b) Position/status Chief Strategy Officer
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 October 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- --------------------------------
GBP15.275 62.115 (personal contribution)
---------- --------------------------------
GBP15.275 116.331 (personal contribution)
---------- --------------------------------
GBP15.275 84.422 (personal contribution)
---------- --------------------------------
GBP15.275 62.115 (personal contribution)
---------- --------------------------------
GBP15.275 116.331 (personal contribution)
---------- --------------------------------
GBP15.275 84.409 (personal contribution)
---------- --------------------------------
GBP15.275 62.115 (matching shares)
---------- --------------------------------
GBP15.275 116.331 (matching shares)
---------- --------------------------------
GBP15.275 84.422 (matching shares)
---------- --------------------------------
GBP15.275 62.115 (matching shares)
---------- --------------------------------
GBP15.275 116.331 (matching shares)
---------- --------------------------------
GBP15.275 84.409 (matching shares)
---------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
1,051.446
GBP15.275
=== ======================== ================================================
e) Date of the transaction 2017-10-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Ms C Thomas
=== ======================== ================================================
b) Position/status SVP, Human Resources
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 October 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- --------------------------------
GBP15.275 83.607 (personal contribution)
---------- --------------------------------
GBP15.275 170.189 (personal contribution)
---------- --------------------------------
GBP15.275 127.067 (personal contribution)
---------- --------------------------------
GBP15.275 83.594 (personal contribution)
---------- --------------------------------
GBP15.275 170.189 (personal contribution)
---------- --------------------------------
GBP15.275 127.067 (personal contribution)
---------- --------------------------------
GBP15.275 83.607 (matching shares)
---------- --------------------------------
GBP15.275 170.189 (matching shares)
---------- --------------------------------
GBP15.275 127.067 (matching shares)
---------- --------------------------------
GBP15.275 83.594 (matching shares)
---------- --------------------------------
GBP15.275 170.189 (matching shares)
---------- --------------------------------
GBP15.275 127.067 (matching shares)
---------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
1,523.426
GBP15.275
=== ======================== ================================================
e) Date of the transaction 2017-10-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr P C Thomson
=== ======================== ================================================
b) Position/status President, Global Affairs
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 October 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- --------------------------------
GBP15.275 56.787 (personal contribution)
---------- --------------------------------
GBP15.275 104.127 (personal contribution)
---------- --------------------------------
GBP15.275 79.994 (personal contribution)
---------- --------------------------------
GBP15.275 56.787 (matching shares)
---------- --------------------------------
GBP15.275 104.127 (matching shares)
---------- --------------------------------
GBP15.275 79.994 (matching shares)
---------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
481.816
GBP15.275
=== ======================== ================================================
e) Date of the transaction 2017-10-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr D E Troy
=== ======================== ===============================================
b) Position/status SVP & General Counsel
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 12 October 2017 on ADSs
held in the Company's 2009 Deferred Annual
Bonus Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- -------------------------------
$41.020 43.227 (personal contribution)
--------- -------------------------------
$41.020 97.329 (personal contribution)
--------- -------------------------------
$41.020 80.611 (personal contribution)
--------- -------------------------------
$41.020 43.227 (personal contribution)
--------- -------------------------------
$41.020 97.329 (personal contribution)
--------- -------------------------------
$41.020 80.599 (personal contribution)
--------- -------------------------------
$41.020 43.227 (matching shares)
--------- -------------------------------
$41.020 97.329 (matching shares)
--------- -------------------------------
$41.020 80.611 (matching shares)
--------- -------------------------------
$41.020 43.227 (matching shares)
--------- -------------------------------
$41.020 97.329 (matching shares)
--------- -------------------------------
$41.020 80.599 (matching shares)
--------- -------------------------------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
884.644
$41.020
=== ======================== ===============================================
e) Date of the transaction 2017-10-12
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Dr P J T Vallance
=== ======================== ================================================
b) Position/status President, R&D
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 October 2017
on Ordinary Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- --------------------------------
GBP15.275 123.070 (personal contribution)
---------- --------------------------------
GBP15.275 200.197 (personal contribution)
---------- --------------------------------
GBP15.275 138.016 (personal contribution)
---------- --------------------------------
GBP15.275 123.070 (personal contribution)
---------- --------------------------------
GBP15.275 200.197 (personal contribution)
---------- --------------------------------
GBP15.275 138.016 (personal contribution)
---------- --------------------------------
GBP15.275 123.070 (matching shares)
---------- --------------------------------
GBP15.275 200.197 (matching shares)
---------- --------------------------------
GBP15.275 138.016 (matching shares)
---------- --------------------------------
GBP15.275 123.070 (matching shares)
---------- --------------------------------
GBP15.275 200.197 (matching shares)
---------- --------------------------------
GBP15.275 138.016 (matching shares)
---------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
1,845.132
GBP15.275
=== ======================== ================================================
e) Date of the transaction 2017-10-12
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEQLFFDBFEFBF
(END) Dow Jones Newswires
October 16, 2017 11:52 ET (15:52 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
